Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trial of Two-Dose Standard Measles Vaccination Schedule: Long-Term Impact on Morbidity and Mortality of a Two-Dose Vaccination Schedule at 6 and 9 Months of Age Compared With a Standard Regimen of One Dose at 9 Months of Age

NCT00168662 is registered in ClinicalTrials.gov with Bandim Health Project as lead sponsor.

NCT NCT00168662
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00168662 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trial of Two-Dose Standard Measles Vaccination Schedule: Long-Term Impact on Morbidity and Mortality of a Two-Dose Vaccination Schedule at 6 and 9 Months of Age Compared With a Standard Regimen of One Dose at 9 Months of Age
Lead sponsor
Bandim Health Project
Phase
Phase 4
Overall status
Completed
Start date
March 31, 1995
Completion date
January 31, 2006
Enrollment
7,800
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

measles